查看购物车
  • Traditional Chinese
  • English
  • Japanese
体外肺模型市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：按类型、应用、最终用户及地理划分
市场调查报告书
商品编码
1761169

体外肺模型市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：按类型、应用、最终用户及地理划分

In Vitro Lung Models Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 231 Pages | 订单完成后即时交付

价格

体外肺模型市场规模预计将从2024年的4.4635亿美元增加到2031年的15.3011亿美元。预计该市场在2025-2031年期间的复合年增长率将达到19.4%。推动市场成长的主要因素包括呼吸系统疾病盛行率的飙升以及体外模型作为动物试验替代方案的日益普及。此外，3D培养和人工智慧在肿瘤学中的应用有望在预测期内推动市场发展。然而，缺乏熟练的专业人员是市场发展的限制因素之一。

根据全球慢性阻塞性肺病倡议组织发布的报告，全球约有6500万人患有阻塞性肺病（COPD），每年近300万人死于该疾病，是全球第四大致死原因。根据2023年美国肺臟协会的资料，约有3,400万美国人患有气喘和COPD等慢性肺部疾病。 2022年，约有1,170万成年人（占美国人口的4.6％）被诊断出患有COPD。根据2020年《欧洲呼吸杂誌》的一篇文章，据报欧洲有3658万名COPD患者，预计到2050年将达到4945万，相对增长35.2％。随着发展中国家吸烟率的上升和高收入国家人口老化，预计未来四十年COPD的盛行率将上升。根据世界卫生组织 (WHO) 估计，到 2030 年，COPD 将成为全球主要死亡原因之一，预计到 2060 年，每年将有超过 540 万人死于 COPD 及相关疾病。

因此，呼吸系统疾病正在刺激对先进研究模型的需求，以了解疾病机制并开发有效的治疗方法。

体外肺模型，例如精密切割肺切片 (PCLS)，可用于研究气道收缩和炎症，从而有助于评估气喘和其他呼吸系统疾病的新型治疗标靶。目前已开发出用于复製人体肺部生理状况的晶片肺装置。密西根大学的「晶片肺」装置利用在带有微通道的塑胶晶片上培养的人体肺组织细胞来模拟肺部内部状况，为疾病研究提供新的见解。因此，对有效治疗和研究模型日益增长的需求推动了体外肺模型市场的成长。

此外，二维 (2D) 细胞培养（或单层细胞培养）因其成本效益高、通量高、易于复製和结果解读等特点，在细胞生物学中被广泛用于疾病研究和药物筛选。然而，它们无法复製活体患者肿瘤三维肿瘤微环境 (TME) 中复杂的动态交互作用网络。这限制了它们模拟癌症行为和药物反应的能力，也限制了它们在二维培养中从患者活检样本中分离和维持癌细胞系的能力。传统的二维细胞培养虽然是基础技术，但无法复製肺癌体内复杂的TME和细胞交互作用。随着癌症研究的进展，越来越多的动物被用于创建动物模型。这些动物包括小鼠、大鼠和其他类似物种。然而，动物模型在将临床前研究发现转化为有效临床治疗方面的成功率较低；这引发了人们对其作为人体疗效预测指标的可靠性的担忧。为了突破这些局限性，研究正转向更生理相关的人体体外模型（3D细胞培养模型），例如球状体、类器官、类肿瘤和微流体系统，这些模型可以更好地模拟临床观察到的肿瘤微环境（TME）、基因表现和药物反应。这些模型对于验证药物疗效和改进临床前测试至关重要，尤其是在肺癌研究中。将3D模型整合到药物筛选对于验证2D培养结果和评估抗癌药物的效果至关重要。这些方法已被证明对癌症药物筛选卓有成效，并正在成为塑造未来肺癌研究和治疗发展的关键工具。 3D细胞培养模型在肺癌药理学研究中的应用代表着理解和治疗肺部疾病方法的典范转移。

比较公司分析基于产品组合（产品满意度、产品特性和可用性）、近期市场发展（併购、新产品发布和改进、投资和融资、奖项、协议、合作与伙伴关係、认可和扩张）以及地理位置，对体外肺模型市场进行评估和分类，以帮助企业更好地做出决策并了解竞争格局。该报告深入探讨了全球体外肺模型市场领先供应商近期的重大发展和创新。主要市场参与者包括 MatTek Corp、Lonza Group AG、Emulate, Inc、CN Bio Innovations Ltd、PromoCell GmbH、Charles River Laboratories International Inc、MIMETAS BV、InSphero AG、Organovo Holdings Inc、Draper, Inc、Epithelix、AlveoliX AG 和美国培养物保藏中心 (ATCC)。

根据类型，市场分为 3D 模型和 2D 模型。 2024 年，3D 模型占据了体外肺模型市场的最大份额，预计在 2024-2031 年期间将实现最高的复合年增长率。

3D肺模型能够精准复製人体肺组织的复杂结构和细胞交互作用。其增强的生理相关性使其在药物研发、毒性测试和疾病建模中具有不可估量的价值。 3D肺模型的主要类型包括球状体、类器官和精密切割肺切片（PCLS）。在3D模型中，细胞在三维结构中培养，这比传统的2D模型更具优势。这些模型能够精确复製肺部的结构和微环境，从而能够精确模拟生理状况。因此，使用3D模型进行药物和治疗研究往往比基于2D模型或动物模型的结果更准确、更可靠。

根据应用，体外肺模型市场细分为药物发现和毒理学研究、生理学研究、再生医学等。 2024年，药物发现和毒理学研究领域占据体外肺模型市场的最大份额。

根据最终用户，体外肺模型市场细分为製药和生物技术公司、学术和研究机构以及其他。製药和生物技术公司在2024年占据了体外肺部模型市场的最大份额。

体外肺模型市场的公司采用各种有机和无机成长策略。有机成长策略主要包括产品发布和产品批准。市场上常见的无机成长策略包括收购、合作和伙伴关係。这些成长策略使市场参与者能够拓展业务，增强地域影响力，并促进整体市场成长。此外，收购和伙伴关係等策略有助于巩固客户群并扩展产品组合。以下列出了体外肺模型市场主要参与者的一些重要进展。

2024年9月，专注于体外人体组织开发的生物技术公司MatTek Life Sciences宣布将其器官型人体组织授权给位于中国的生命科学实验室CellEx。此次策略合作标誌着人体组织在研究、药物开发和安全评估应用方面的进步和应用的里程碑。

2023年6月，下一代体外模型供应商Emulate, Inc.宣布透过早期试用计画推出Emulate Chip-A1 Accessible Chip。这款全新的器官晶片设计在原有的Chip-S1（透过模拟组织-血管界面，并考虑相关的生物力学力，例如拉伸和流动）的基础上进行了扩展，允许用户在上皮培养室内创建更厚的组织，并应用额外的药物治疗方案，包括局部用药或雾化给药。

目录

第一章：简介

第二章：执行摘要

  • 分析师市场展望

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • 假设和局限性

第四章：体外肺模型市场格局

  • 概述
  • PEST分析
  • 监管情景

第五章：体外肺模型市场－关键市场动态

  • 体外肺部模型市场－关键市场动态
  • 市场驱动因素
    • 呼吸系统疾病发生率激增
    • 越来越多地采用体外模型作为动物试验的替代方案
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 体外模式资金和投资激增
  • 未来趋势
    • 3D培养与人工智慧在肿瘤学的应用
  • 驱动因素和限制因素的影响：

第六章：体外肺部模型市场-全球市场分析

  • 2021-2031年体外肺模型市场收入
  • 体外肺部模型市场预测分析

第七章：体外肺模型市场分析－依类型

  • 3D模型
  • 2D模型

第 8 章：体外肺部模型市场分析 - 按应用

  • 药物研发与毒理学研究
  • 生理学研究
  • 再生医学
  • 其他的

第九章：体外肺模型市场分析－依最终用户

  • 製药和生物技术公司
  • 学术和研究机构
  • 其他的

第 10 章：体外肺部模型市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 概述
  • 新产品开发
  • 合併与收购
  • 伙伴关係与合作
  • 其他商业策略

第 12 章：竞争格局

  • 2024年全球公司市占率分析

第十三章：公司简介

  • MatTek Corp
  • Lonza Group AG
  • Emulate, Inc.
  • CN Bio Innovations Ltd
  • Merck KGaA
  • PromoCell GmbH
  • Charles River Laboratories International Inc
  • MIMETAS BV
  • InSphero AG
  • Organovo Holdings Inc
  • Draper, Inc.
  • TissUse GmbH
  • Epithelix
  • AlveoliX AG
  • American Type Culture Collection (ATCC)

第 14 章：附录

Product Code: TIPRE00006695

The In Vitro lung models market size is projected to reach US$ 1,530.11 million by 2031 from US$ 446.35 million in 2024. The market is estimated to register a CAGR of 19.4% during 2025-2031. Major factors driving the market growth include a surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing. Further, Applications of 3D cultures and AI in oncology is likely to boost the market during the forecast period. However, lack of skilled professionals are among the market deterrents.

According to a report published by the Global Initiative on Chronic Obstructive Lung Disease, ~65 million people suffer from obstructive pulmonary disease (COPD), and nearly 3 million people die from the disease each year, making it the fourth leading cause of mortality worldwide. According to the 2023 American Lung Association data, ~34 million Americans were affected by chronic lung diseases such as asthma and COPD. In 2022, ~11.7 million adults, or 4.6% of the population in the US, were diagnosed with COPD. As per an article published in the European Respiratory Journal in 2020, 36.58 million Europeans were reported to have COPD, which is projected to reach 49.45 million by 2050, representing a 35.2% relative increase. With the growing prevalence of smoking in developing countries and the aging population in high-income countries, the COPD prevalence is projected to rise over the next forty years. As per the World Health Organization (WHO) estimates, COPD will become one of the leading causes of death worldwide by 2030, and it is estimated that by 2060, there will be more than 5.4 million deaths yearly due to COPD and related conditions.

Therefore, respiratory diseases is spurring the demand for advanced research models to understand disease mechanisms and develop effective treatments.

In vitro lung models, such as precision-cut lung slices (PCLS), allow the study of airway constriction and inflammation, facilitating the evaluation of novel therapeutic targets for asthma and other respiratory conditions. Lung-on-a-chip devices have been developed to replicate the physiological conditions of the human lung. The University of Michigan's "lung-on-a-chip" device uses human lung-tissue cells cultured on a plastic chip with microscopic channels to simulate the conditions inside the lungs, providing new insights into diseases. Thus, the increasing demand for effective treatments and research models fuels the growth of the in vitro lung model market.

Moreover, two-dimensional (2D) cell cultures, or monolayers, are widely used in cellular biology to study diseases and for drug screening due to their cost-effectiveness, high throughput, easy replication, and results interpretation. However, they fall short in replicating the complex network of dynamic interactions present in the three-dimensional tumor microenvironment (TME) of living patient tumors. This aspect limits their ability to model cancer behavior and drug responses, as well as to isolate and maintain cancer cell lines from patient biopsies in 2D cultures. Traditional 2D cell cultures, while foundational, fall short in replicating the intricate TME and cellular interactions that characterize lung cancers in vivo. As cancer research advances, an increasing number of animals are being utilized in the creation of animal models. These animals include mice, rats, and other similar species. However, animal models exhibit low success rates in translating preclinical findings into effective clinical treatments; this has raised concerns about their reliability as predictors of human responses. To address these limitations, research is shifting toward more physiologically relevant human in vitro models (3D cell culture models)-such as spheroids, organoids, tumoroids, and microfluidic systems-that better mimic the TME, gene expression, and drug responses observed clinically. These models are critical for validating drug efficacy and improving preclinical testing, especially in lung cancer research. Integrating 3D models in drug screening is essential to validate findings from 2D cultures and assess the effects of anticancer drugs. Such approaches have proven to be fruitful for cancer drug screening and are emerging as a pivotal tool in shaping the future of lung cancer research and therapeutic development. The use of 3D cell culture models in lung cancer pharmacology research represents a paradigm shift in the approach toward understanding and treating lung diseases.

The comparative company analysis evaluates and categorizes the in vitro lung models market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global in vitro lung models market. The key market players are MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC).

Based on type, the market is divided into 3D Models and 2D Models. The 3D Models segment held the largest In Vitro Lung Model Market share in 2024, and it is expected to register the highest CAGR during 2024-2031.

3D lung models replicate the complex architecture and cellular interactions of human lung tissue accurately. The enhanced physiological relevance makes them invaluable for drug discovery, toxicity testing, and disease modeling. The primary types of 3D lung models include spheroids, organoids, and precision-cut lung slices (PCLS). In 3D models, cells are cultured within a three-dimensional structure, offering advantages over traditional 2D models. These models closely replicate the architecture and microenvironment of the lung, enabling accurate simulation of physiological conditions. As a result, drug and therapeutic studies using 3D models tend to yield more accurate and reliable results than those derived from 2D models or animal models.

By application, In Vitro Lung Model market is segmented into drug discovery and toxicology studies, physiological research, regenerative medicine, and others. The drug discovery and toxicology studies segment held the largest share of the in vitro lung model market in 2024.

Per end user, In Vitro Lung Model market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the In Vitro lung model market in 2024.

Various organic and inorganic strategies are adopted by companies operating in the in vitro lung models market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the in vitro lung models market are listed below.

In September 2024, MatTek Life Sciences, a biotech company specializing in the development of in vitro human tissues, announced the licensing of its organotypic human tissues to CellEx, a life science laboratory based in China. This strategic collaboration marks a milestone in the advancement and utilization of human tissues for research, pharmaceutical development, and safety assessment applications.

In June 2023, Emulate, Inc., a provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1 Accessible Chip through an early access program. This new Organ-Chip design expands on the original Chip-S1-which models tissue-vascular interfaces with relevant biomechanical forces such as stretch and flow-by allowing users to create thicker tissues within the epithelial culture chamber and apply additional drug treatment options, including topical or aerosolized applications.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. In-Vitro Lung Model Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Regulatory Scenario

5. In-Vitro Lung Model Market - Key Market Dynamics

  • 5.1 In-Vitro Lung Model Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Surging Prevalence of Respiratory Diseases
    • 5.2.2 Rising Adoption of In Vitro Models as an Alternative to Animal Testing
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Surging Funding and Investments for In Vitro Models
  • 5.5 Future Trends
    • 5.5.1 Application of 3D Cultures and AI in Oncology
  • 5.6 Impact of Drivers and Restraints:

6. In-Vitro Lung Model Market - Global Market Analysis

  • 6.1 In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • 6.2 In-Vitro Lung Model Market Forecast Analysis

7. In-Vitro Lung Model Market Analysis - by Type

  • 7.1 3D Model
    • 7.1.1 Overview
    • 7.1.2 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 2D Model
    • 7.2.1 Overview
    • 7.2.2 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

8. In-Vitro Lung Model Market Analysis - by Application

  • 8.1 Drug Discovery and Toxicology Studies
    • 8.1.1 Overview
    • 8.1.2 Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Physiological Research
    • 8.2.1 Overview
    • 8.2.2 Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

9. In-Vitro Lung Model Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Academic and Research Institutes
    • 9.2.1 Overview
    • 9.2.2 Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

10. In-Vitro Lung Model Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America In-Vitro Lung Model Market Overview
    • 10.2.2 North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.2.3.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.4.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.5.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.2.2 United States: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.2.3 United States: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.6.3 Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.3.2 Canada: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.6.4 Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.4.2 Mexico: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: In-Vitro Lung Model Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe In-Vitro Lung Model Market Overview
    • 10.3.2 Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: In-Vitro Lung Model Market Breakdown, by Type
      • 10.3.3.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: In-Vitro Lung Model Market Breakdown, by Application
      • 10.3.4.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.5.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.2.2 Germany: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.2.3 Germany: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.3 France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 France: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.3.2 France: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.3.3 France: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.4 United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 United Kingdom: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.4.2 United Kingdom: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.4.3 United Kingdom: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.5 Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.5.2 Italy: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.5.3 Italy: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.6 Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.6.2 Spain: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.6.3 Spain: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.7.2 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: In-Vitro Lung Model Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific In-Vitro Lung Model Market Overview
    • 10.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
      • 10.4.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.4.5 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.2 China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.2.1 China: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.2.2 China: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.2.3 China: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.3 Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.3.1 Japan: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.3.2 Japan: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.3.3 Japan: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.4 India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.4.1 India: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.4.2 India: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.4.3 India: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.5 South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.5.1 South Korea: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.5.2 South Korea: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.5.3 South Korea: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.6 Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.6.1 Australia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.6.2 Australia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.6.3 Australia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.7 Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.7.1 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.7.2 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.7.3 Rest of APAC: In-Vitro Lung Model Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa In-Vitro Lung Model Market Overview
    • 10.5.2 Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.2.2 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.3 South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.3.2 South Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.4.2 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.5.2 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America In-Vitro Lung Model Market Overview
    • 10.6.2 South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.6.3.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.6.4.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.5.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.2.2 Brazil: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.3 Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.3.2 Argentina: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.4.2 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 New Product Development
  • 11.3 Merger and Acquisition
  • 11.4 Partnerships and Collaborations
  • 11.5 Other Business Strategies

12. Competitive Landscape

  • 12.1 Global Company Market Share Analysis, 2024

13. Company Profiles

  • 13.1 MatTek Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Lonza Group AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Emulate, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 CN Bio Innovations Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Merck KGaA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 PromoCell GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
  • 13.7 Charles River Laboratories International Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 MIMETAS BV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Organovo Holdings Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Draper, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 TissUse GmbH
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
  • 13.13 Epithelix
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Financial Overview
    • 13.13.4 SWOT Analysis
    • 13.13.5 Key Developments
  • 13.14 AlveoliX AG
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 American Type Culture Collection (ATCC)
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. In-Vitro Lung Model Market Segmentation
  • Table 2. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 5. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 6. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 11. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 12. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 19. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 20. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 25. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 26. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 29. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 30. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 31. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 32. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 33. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 34. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 35. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 36. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 37. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 38. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 39. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 40. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 41. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 42. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 43. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 44. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 45. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 46. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 49. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 50. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 51. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 52. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 53. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 54. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 55. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 56. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 57. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 58. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 59. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 61. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 62. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 65. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 66. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 67. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 68. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 69. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 70. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 73. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 74. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 77. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 78. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 79. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 80. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 81. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 82. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 83. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 84. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 85. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 86. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 87. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 88. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 89. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 90. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 93. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 94. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 95. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 96. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 97. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 98. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 99. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 100. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 101. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 102. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 105. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 106. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 109. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 110. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 111. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 112. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 113. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 114. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 115. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 116. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 117. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 118. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 119. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 120. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 121. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 122. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 123. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 124. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 127. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 128. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 129. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 130. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 131. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 132. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 133. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 134. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 135. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 136. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 137. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 138. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 139. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 140. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 141. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 142. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 143. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 144. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 145. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 146. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 147. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 148. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 149. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 150. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 151. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 152. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 155. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 156. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 157. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 158. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 159. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 160. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 161. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 162. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 163. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 164. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 165. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 166. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 167. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 168. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 169. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 170. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 171. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 172. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 173. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 174. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 175. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 176. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 177. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 178. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. Glossary of Terms, In-Vitro Lung Model Market

List Of Figures

  • Figure 1. In-Vitro Lung Model Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • Figure 5. In-Vitro Lung Model Market Share (%) - by Type (2024 and 2031)
  • Figure 6. 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. In-Vitro Lung Model Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. In-Vitro Lung Model Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. In-Vitro Lung Model Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 20. North America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 28. Europe: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 39. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 41. China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 49. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 50. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 51. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 58. South and Central America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 59. South and Central America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 60. South and Central America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 61. Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Global Company Market Share Analysis, 2024